Home/ Stocks/ ANL

Adlai Nortye Ltd. American Depositary Shares

ANL XNAS

$13.25 -2.53 (-16.14%) ▼ 15-min delayed

Open

$15.40

High

$15.48

Low

$7.20

Volume

1.11M

Market Cap

$832.25M

About Adlai Nortye Ltd. American Depositary Shares

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Employees: 109 Website →

TickerDaily Coverage

Why Is Adlai Nortye Ltd. American Depositary Shares (ANL) Stock Down 54.1% Today?

Market News Alex Chen · 8h ago

Adlai Nortye Ltd. American Depositary Shares (ANL) plunged 54.1% to $7.20 on Wednesday, April 15,...

View All Coverage →

Get ANL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Adlai Nortye Ltd. American Depositary Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.